Clinical monitoring of safety and functionality of a non-medicated patch for pain alleviation associated to dysmenorrhea.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
06 09 2019
Historique:
received: 11 06 2018
accepted: 26 07 2018
entrez: 4 10 2019
pubmed: 4 10 2019
medline: 1 9 2020
Statut: epublish

Résumé

FIT® Lady patch is an easy-to-use class I medical device, developed to relieve pain associate to menstrual period, without pharmacological substances. The patch is based on far infrared (FIR) electromagnetic waves reflection properties that normally are emitted from the body, as a consequence of body heat dispersion between the difference of cutaneous body and ambient temperature. Consequently, infrared (IR) waves are reflected and resorbed at cutaneous level and thermal energy again locally introduced leads to a better microcirculation. Although biological IR waves properties and mechanisms of action are extensively studied, there are still few references on patches based on FIR properties. The aim of this study was the evaluation of FIR technology applied to FIT® Lady patch thought to be used to alleviate pain associated to menstrual period (dysmenorrhea). The FIT® Lady patch medical device (active patch) was evaluated in comparison with a placebo patch, in order to assess its action in reducing pain related to menstrual period in 40 women patients enrolled according to specific inclusion/exclusion criteria. This study confirmed a good tolerability of the product, by demonstrating the ability to significantly reduce inconvenience and feeling of pain. The mineral that was responsible of the reflection activity (titanium dioxide), conveniently entrapped in a patch, was able to work without any active substances in contact with and absorbed from the skin.

Identifiants

pubmed: 31580316
doi: 10.23750/abm.v90i3.7370
pmc: PMC7233733
doi:

Substances chimiques

titanium dioxide 15FIX9V2JP
Titanium D1JT611TNE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-292

Références

Psychother Psychosom. 2005;74(5):288-94
pubmed: 16088266
J Cosmet Dermatol. 2011 Mar;10(1):30-5
pubmed: 21332913
Reumatismo. 2012 Dec 20;64(6):388-94
pubmed: 23285483
Evid Based Complement Alternat Med. 2012;2012:240314
pubmed: 23320024
Pain Med. 2015 Dec;16(12):2243-55
pubmed: 26177393
Acta Biomed. 2016 Apr 15;87 Suppl 1:90-4
pubmed: 27104326
Intern Med. 2008;47(16):1473-6
pubmed: 18703857
Complement Ther Med. 2011 Aug;19(4):187-93
pubmed: 21827932
J Altern Complement Med. 2014 Feb;20(2):123-9
pubmed: 24152215
J Altern Complement Med. 2012 Feb;18(2):175-9
pubmed: 22339105

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH